Nihon Kohden Corporation (NHNKY)
OTCMKTS
· Delayed Price · Currency is USD
13.24
+0.46 (3.58%)
Jun 13, 2025, 3:52 PM EDT
Nihon Kohden Revenue
In the fiscal year ending March 31, 2025, Nihon Kohden had annual revenue of 225.42B JPY with 1.55% growth. Nihon Kohden had revenue of 66.95B in the quarter ending March 31, 2025, with 1.72% growth.
Revenue
225.42B JPY
Revenue Growth
+1.55%
P/S Ratio
1.27
Revenue / Employee
38.27M JPY
Employees
5,891
Market Cap
1.91B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 225.42B | 3.44B | 1.55% |
Mar 31, 2024 | 221.99B | 15.38B | 7.45% |
Mar 31, 2023 | 206.60B | 1.47B | 0.72% |
Mar 31, 2022 | 205.13B | 5.40B | 2.70% |
Mar 31, 2021 | 199.73B | 14.72B | 7.96% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |